• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺受体异聚体复合物及其新出现的功能。

Dopamine receptor heteromeric complexes and their emerging functions.

作者信息

George Susan R, Kern Andras, Smith Roy G, Franco Rafael

机构信息

Departments of Medicine and Pharmacology, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada.

Department of Metabolism and Aging, The Scripps Research Institute, Jupiter, FL, USA.

出版信息

Prog Brain Res. 2014;211:183-200. doi: 10.1016/B978-0-444-63425-2.00008-8.

DOI:10.1016/B978-0-444-63425-2.00008-8
PMID:24968781
Abstract

Dopamine neurotransmission is traditionally accepted as occurring through the five dopamine receptors that transduce its signal. Recent evidence has demonstrated that the range of physiologically relevant dopamine signaling complexes is greatly expanded by the ability of dopamine receptors to interact with other dopamine receptors and with receptors of other endogenous signaling ligands. These novel heteromeric complexes have functional properties distinct from the component receptors or are able to modulate the canonical signaling and function of the cognate receptors. These dopamine receptor heteromers provide new insight into physiological mechanisms and pathophysiological processes involving dopamine.

摘要

传统上认为多巴胺神经传递是通过五种转导其信号的多巴胺受体发生的。最近的证据表明,生理相关的多巴胺信号复合物的范围因多巴胺受体与其他多巴胺受体以及其他内源性信号配体的受体相互作用的能力而大大扩展。这些新型异源复合物具有与组成受体不同的功能特性,或者能够调节同源受体的经典信号传导和功能。这些多巴胺受体异聚体为涉及多巴胺的生理机制和病理生理过程提供了新的见解。

相似文献

1
Dopamine receptor heteromeric complexes and their emerging functions.多巴胺受体异聚体复合物及其新出现的功能。
Prog Brain Res. 2014;211:183-200. doi: 10.1016/B978-0-444-63425-2.00008-8.
2
Dopamine and full-field illumination activate D1 and D2-D5-type receptors in adult rat retinal ganglion cells.多巴胺和全场照明激活成年大鼠视网膜神经节细胞中的 D1 和 D2-D5 型受体。
J Comp Neurol. 2012 Dec 1;520(17):4032-49. doi: 10.1002/cne.23159.
3
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.异源多巴胺受体信号复合物:新兴的神经生物学及与疾病的相关性
Neuropsychopharmacology. 2014 Jan;39(1):156-68. doi: 10.1038/npp.2013.148. Epub 2013 Jun 18.
4
A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.一种靶向相互作用界面的肽可破坏多巴胺 D1-D2 受体异聚体,从而在体外和体内阻断信号传导及功能:有效的选择性拮抗作用。
FASEB J. 2014 Nov;28(11):4806-20. doi: 10.1096/fj.14-254037. Epub 2014 Jul 25.
5
The neurobiology of dopamine signaling.多巴胺信号传导的神经生物学
Biosci Rep. 2001 Jun;21(3):247-69. doi: 10.1023/a:1013205230142.
6
Heteromerization of dopaminergic receptors in the brain: Pharmacological implications.脑内多巴胺能受体的异源二聚化:药理学意义。
Pharmacol Res. 2021 Aug;170:105600. doi: 10.1016/j.phrs.2021.105600. Epub 2021 Apr 6.
7
Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.伏隔核中I组代谢型谷氨酸受体激活和III组代谢型谷氨酸受体阻断对D1样和D2样受体激动剂诱导的运动反应的调节作用。
Brain Res. 2008 Mar 10;1198:44-54. doi: 10.1016/j.brainres.2008.01.025. Epub 2008 Jan 18.
8
Detection of receptor heteromers involving dopamine receptors by the sequential BRET-FRET technology.采用序贯生物发光共振能量转移技术检测涉及多巴胺受体的受体异聚体。
Methods Mol Biol. 2013;964:95-105. doi: 10.1007/978-1-62703-251-3_7.
9
Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain.含腺苷受体的寡聚体:它们在大脑中多巴胺和谷氨酸神经传递控制中的作用。
Biochim Biophys Acta. 2011 May;1808(5):1245-55. doi: 10.1016/j.bbamem.2011.02.007. Epub 2011 Feb 18.
10
(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling.(-)-千金藤啶碱是一种强效的泛多巴胺受体拮抗剂,可抑制G蛋白和β-抑制蛋白介导的信号传导。
Psychopharmacology (Berl). 2015 Mar;232(5):917-30. doi: 10.1007/s00213-014-3726-8. Epub 2014 Sep 18.

引用本文的文献

1
Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor-Receptor Interactions.膜异源受体复合物作为二级蛋白质调节剂:通过变构受体-受体相互作用的新型整合机制。
Membranes (Basel). 2024 Apr 25;14(5):96. doi: 10.3390/membranes14050096.
2
Non-canonical interplay between glutamatergic NMDA and dopamine receptors shapes synaptogenesis.谷氨酸能 NMDA 和多巴胺受体之间的非经典相互作用塑造了突触发生。
Nat Commun. 2024 Jan 2;15(1):27. doi: 10.1038/s41467-023-44301-z.
3
The World of GPCR dimers - Mapping dopamine receptor D homodimers in different activation states and configuration arrangements.
GPCR二聚体的世界——绘制处于不同激活状态和构象排列的多巴胺受体D同型二聚体图谱。
Comput Struct Biotechnol J. 2023 Sep 3;21:4336-4353. doi: 10.1016/j.csbj.2023.08.032. eCollection 2023.
4
Integrative multi-dimensional characterization of striatal projection neuron heterogeneity in adult brain.成年大脑中纹状体投射神经元异质性的综合多维度表征
bioRxiv. 2023 Oct 21:2023.05.04.539488. doi: 10.1101/2023.05.04.539488.
5
Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson's Disease: A Novel and Futuristic Approach.治疗帕金森病中大麻素积极作用的分子机制:一种新颖而有前途的方法。
Neurotox Res. 2023 Feb;41(1):85-102. doi: 10.1007/s12640-022-00619-y. Epub 2022 Dec 26.
6
Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?多巴胺受体:它有可能成为抑郁症的治疗靶点吗?
Front Pharmacol. 2022 Aug 17;13:947785. doi: 10.3389/fphar.2022.947785. eCollection 2022.
7
MiR-4763-3p targeting as a Potential Biomarker and Therapeutic Target for Schizophrenia.MiR-4763-3p靶向作用作为精神分裂症的潜在生物标志物和治疗靶点
Aging Dis. 2022 Jul 11;13(4):1278-1292. doi: 10.14336/AD.2022.0103.
8
Class A and C GPCR Dimers in Neurodegenerative Diseases.A 类和 C 类 G 蛋白偶联受体二聚体在神经退行性疾病中的作用。
Curr Neuropharmacol. 2022;20(11):2081-2141. doi: 10.2174/1570159X20666220327221830.
9
The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB Receptors.与正构位点和/或别构位点的结合模式是靶向大麻素CB受体药物治疗潜力的基础。
Front Pharmacol. 2022 Feb 16;13:852631. doi: 10.3389/fphar.2022.852631. eCollection 2022.
10
Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review.炎症性肠病中的胃肠道多巴胺:系统评价。
Int J Mol Sci. 2021 Nov 29;22(23):12932. doi: 10.3390/ijms222312932.